[{"data":1,"prerenderedAt":158},["ShallowReactive",2],{"drug-atropine-eye":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":21,"regimens":34,"contraindications":59,"warnings":69,"renal":70,"monitoring":71,"interactions":72,"review":73,"examples":76,"atc":82,"iran":84,"links":104,"populations":119,"usApproval":153},"atropine-eye",1,{"fa":7,"en":8},"قطره چشمی آتروپین ۱٪","Atropine 1% eye drops","sensory-organs",{"fa":11,"en":12},"سیکلوپلژیک","Cycloplegic \u002F mydriatic",[14],{"name":15,"market":16},"Isopto Atropine","US",[18,19,20],"atropine eye","قطره آتروپین","آتروپین چشمی",[22],{"id":23,"form":24,"route":25,"label":26,"concentration":27,"markets":29,"refs":30},"drops","eye-drops","ophthalmic","1% ophthalmic solution",{"amount":5,"unit":28,"perUnit":28},"drop",[16],[31],{"source":32,"section":33},"fda-atropineeye","3",[35],{"id":36,"disease":37,"label":38,"population":41,"type":45,"unit":28,"dose":46,"refs":47,"notes":50},"dil","eye-examination",{"fa":39,"en":40},"سیکلوپلژی\u002Fمیدریاز — ۱ قطره ۴۰ دقیقه پیش از زمان لازم","Cycloplegia\u002Fmydriasis — 1 drop 40 min before needed",{"minAge":42},{"value":43,"unit":44},3,"month","fixed",{"perDose":5,"dosesPerDay":5},[48],{"source":32,"section":49},"2",[51],{"text":52,"refs":55},{"fa":53,"en":54},"بزرگسال و کودک ۳ سال به بالا: تا ۲ بار در روز در صورت نیاز. در کودکان خطر جذب سیستمیک.","Adults and children ≥3 y: up to twice daily if needed. Systemic absorption risk in children.",[56,57],{"source":32,"section":49},{"source":32,"section":58},"8.4",[60],{"id":61,"severity":62,"text":63,"refs":66},"hyper","block",{"fa":64,"en":65},"حساسیت به اجزا.","Hypersensitivity to components.",[67],{"source":32,"section":68},"4",[],[],[],[],{"status":74,"reviewer":75,"date":75},"unverified",null,[77],{"regimen":36,"formulation":23,"input":78,"expect":81},{"ageYears":79,"weightKg":80},10,30,{"perDose":5},[83],"S01FA01",{"status":85,"forms":86,"refs":99},"registered",[87,91,95],{"code":88,"en":89,"fa":90},"00118","ATROPINE SULFATE 0.5% 10ML OPH DROP","قطره چشمی آتروپین سولفات ۰٫۵ درصد ۱۰ میلی‌لیتر",{"code":92,"en":93,"fa":94},"00120","ATROPINE SULFATE 1% 3.5G OPH OINT","پماد آتروپین سولفات ۱ درصد ۳٫۵ گرم",{"code":96,"en":97,"fa":98},"00121","ATROPINE SULFATE 1%10ML OPH DROP","قطره چشمی آتروپین سولفات ۱ درصد ۱۰ میلی‌لیتر",[100],{"source":101,"section":102,"url":103},"darooyab-generic","G-4561\u002FAtropine-Sulfate-Ophthalmic","https:\u002F\u002Fwww.darooyab.ir\u002FG-4561\u002FAtropine-Sulfate-Ophthalmic",[105,109,113,116],{"kind":106,"url":107,"label":108},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=219013","ANDA219013",{"kind":110,"url":111,"label":112},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=b39f5876-5d6f-4a8f-bd24-bd4be24ff568","FDA Atropine 1% eye",{"kind":114,"url":115,"label":83},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=S01FA01",{"kind":117,"url":103,"label":118},"darooyab","Atropine-Sulfate-Ophthalmic",{"pregnancy":120,"lactation":129,"pediatric":137,"geriatric":144},{"level":121,"text":122,"quote":125,"refs":126},"caution",{"fa":123,"en":124},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Risk Summary There are no adequate and well-controlled studies of atropine sulfate administration in pregnant women to inform a drug-associated risk.",[127],{"source":32,"section":128},"8.1",{"level":121,"text":130,"quote":133,"refs":134},{"fa":131,"en":132},"برچسب: در شیردهی با احتیاط؛ متن برچسب را ببینید.","Label: use with caution while breastfeeding; see the label text.","Risk Summary There is no information to inform risk regarding the presence of atropine in human milk following ocular administration of atropine sulfate to the mother.",[135],{"source":32,"section":136},"8.2",{"level":121,"text":138,"quote":141,"refs":142},{"fa":139,"en":140},"برچسب برای کودکان شرط، محدودیت سنی یا نکته دارد؛ جمله برچسب در زیر آمده است.","The label has conditions, age limits or notes for children; the label sentence is quoted below.","The safety and effectiveness of atropine sulfate ophthalmic solution 1% have been established in pediatric patients aged 3 months and older.",[143],{"source":32,"section":58},{"level":145,"text":146,"quote":149,"refs":150},"ok",{"fa":147,"en":148},"برچسب: در سالمندان تفاوت یا تنظیم دوز خاصی ذکر نشده.","Label: no specific difference or dose adjustment stated for older adults.","No overall differences in safety and effectiveness have been observed between elderly and younger adult patients.",[151],{"source":32,"section":152},"8.5",{"kind":154,"refs":155,"id":108},"ANDA",[156],{"source":32,"section":157},"SPL approval \u002F marketing category",1792092023257]